Please assess the completion status of the following clinical trial:

Trial Title: Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* early labor (\>=2cm but =\<6cm cervical dilation)~* at least 12 years of age~* have an assigned ASA physical status 1 or 2~* singleton pregnancy~Exclusion Criteria:~* contraindications to neuraxial anesthesia~* with allergies to drugs used in the study~* have an assigned ASA status 3 or 4~* advanced labor (\> 6cm cervical dilation)~* less than 12 years of age~* Patients with the potential for distorted epidural anatomy, such as Harrington rods or prior back surgery, will also be excluded.

- Gender: FEMALE
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- tetracaine 2mg (Type: ACTIVE_COMPARATOR): None
- Bupivacaine 2 mg (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).